United Kingdom· GB-APID-31221711000001107
Tinzaparin sodium 4,500units/0.45ml solution for injection pre-filled syringes
A tinzaparin product containing tinzaparin, registered in United Kingdom by LEO Pharma. The same ATC class is registered in 9 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Tinzaparin is registered in 9 of 19 countries.
Countries holding a registration under ATC B01AB10 (tinzaparin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 3 of them publish a price we can compare per daily dose
Tinzaparin · ATC B01AB10
9 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Tinzaparin
- Manufacturer
- LEO Pharma
- Country
- United Kingdom (GB)
- ATC code
- B01AB10
- ATC class
- Tinzaparin
- Defined daily dose
- 3.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5702191011760
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
162 interactions on record for tinzaparin.
Graded by severity as the source publishes them — 94 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tinzaparin · interactions on record
162 records
- 94 severe
- 68 moderate
Most severe, free to view
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tinzaparin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsInnohep 10.000 IE anti-Xa/0,5 ml, oplossing voor injectieLEO Pharma B.V.
- SwedenInnohep 10 000 anti-Xa IE Injektionsvätska, lösning i förfylld sprutaLEO Pharma AB
- SpainINNOHEP 10.000 UI ANTI-XA/0,5 ML SOLUCION INYECTABLE EN JERINGAS PRECARGADASLeo Pharma A/S
- ItalyINNOHEP*10 siringhe 12.000 UI 0,6 mlLEO PHARMA A/S
- FranceINNOHEP 10 000 UI anti-Xa/0,5 ml, solution injectable en seringue préremplieLABORATOIRES LEO
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Greece · Innohep
- Sweden · Innohep
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b59ed6c1-2394-468f-9a4c-b95abbeb9059 GET /v1/drugs/b59ed6c1-2394-468f-9a4c-b95abbeb9059?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "31221711000001107",
"desc": "Tinzaparin sodium 4,500units/0.45ml solution for injection pre-filled syringes (LEO Pharma)",
"form": "Solution for injection",
"vpid": "35919411000001106",
"source": "dmd",
"vtm_id": "777776004",
"strength": "10000 unit",
"substance": "Tinzaparin",
"ingredient": "Tinzaparin sodium",
"supplier_code": "2269001000001104"
}See everything about tinzaparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.